2012-07-09
| Signal | Price | Bias | Subject | Owned |
|---|---|---|---|---|
| COMMENT | $65.610 | CAUTIOUS | NORTH AMERICAN - LARGE | Yes |
Will be splitting the company into 2 parts, pharma side and medical devices. Purchased a generic company out of India last year and India will be providing health care to the general population but will only pay for generic drugs . Currently within a couple of dollars of her target price so she might shave some of her holdings.
Christine Poole
Managing Director,
GlobeInvest Capital Management